The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation

Shahrad Hakimian1 Department of MedicineCorrespondence[email protected]

Yevgeniy Popov1 Department of Medicine

Abbas H Rupawala2 Division of Gastroenterology

Karen Salomon-Escoto3 Division of Rheumatology

Steven Hatch4 Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA

Randall Pellish1 Department of Medicine;2 Division of Gastroenterology

Pages 61-67 | Published online: 27 Feb 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

NcayiyanaJRBassettJWestNPrevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional studyBMC Infect Dis201616166127825307
PubMed Web of Science ®Google Scholar
HoubenRMDoddPJThe global burden of latent tuberculosis infection: a re-estimation using mathematical modellingPLoS Med20161310e100215227780211
PubMed Web of Science ®Google Scholar
ZumlaAGeorgeASharmaVThe WHO 2014 global tuberculosis report – further to goLancet Glob Health201531e10e1225539957
PubMed Web of Science ®Google Scholar
MancusoJDDiffenderferJMGhassemiehBJHorneDJKaoTCThe prevalence of latent tuberculosis infection in the United StatesAm J Respir Crit Care Med2016194450150926866439
PubMed Web of Science ®Google Scholar
PapadakisKATarganSRRole of cytokines in the pathogenesis of inflammatory bowel diseaseAnnu Rev Med20005128929810774465
PubMed Web of Science ®Google Scholar
LinJZiringDDesaiSTNFalpha blockade in human diseases: an overview of efficacy and safetyClin Immunol20081261133017916445
PubMed Web of Science ®Google Scholar
FlynnJLChanJLinPLMacrophages and control of granulomatous inflammation in tuberculosisMucosal Immunol20114327127821430653
PubMed Web of Science ®Google Scholar
KeaneJGershonSWiseRPTuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agentN Engl J Med2001345151098110411596589
PubMed Web of Science ®Google Scholar
MalipeddiASRajendranRKallarackalGDisseminated tuberculosis after anti-TNFalpha treatmentLancet2007369955616217223480
PubMed Web of Science ®Google Scholar
LichtensteinGRFeaganBGCohenRDSerious infection and mortality in patients with Crohn’s disease: more than 5 years of followup in the TREAT registryAm J Gastroenterol201210791409142222890223
PubMed Web of Science ®Google Scholar
RahierJFMagroFAbreuCSecond European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel diseaseJ Crohns Colitis20148644346824613021
PubMed Web of Science ®Google Scholar
KochRAn address on bacteriological researchBr Med J189021546380383
PubMedGoogle Scholar
ChaparasSDVandiviereHMMelvinIKochGBeckerCTuberculin test. Variability with the Mantoux procedureAm Rev Respir Dis198513211751774014862
PubMed Web of Science ®Google Scholar
MenziesDInterpretation of repeated tuberculin tests. Boosting, conversion, and reversionAm J Respir Crit Care Med1999159115219872812
PubMed Web of Science ®Google Scholar
TissotFZanettiGFrancioliPZellwegerJPZyssetFInfluence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?Clin Infect Dis200540221121715655737
PubMed Web of Science ®Google Scholar
MowWSAbreu-MartinMTPapadakisKAPitchonHETarganSRVasiliauskasEAHigh incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapyClin Gastroenterol Hepatol20042430931315067625
PubMed Web of Science ®Google Scholar
AgarwalSDasSKAgarwalGGSrivastavaRSteroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: implications on anti-TNF therapiesInterdiscip Perspect Infect Dis2014201443013424707285
PubMedGoogle Scholar
TaxoneraCPonferradaÁBermejoFEarly tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory bowel diseaseJ Crohns Colitis201711779280028333182
PubMed Web of Science ®Google Scholar
SchoepferAMFlogerziBFalleggerSComparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel diseaseAm J Gastroenterol2008103112799280618684188
PubMed Web of Science ®Google Scholar
Karataş ToğralAMuştu KoryürekÖŞahinMBulutCYağciSEkşioğluHMAssociation of clinical properties and compatibility of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test in patients with psoriasisInt J Dermatol201655662963326498894
PubMed Web of Science ®Google Scholar
BaeWParkKUSongEYComparison of the sensitivity of QuantiFERON-TB gold in-tube and T-SPOT.TB according to patient agePLoS One2016116e015691727258377
PubMed Web of Science ®Google Scholar
AndersenPMunkMEPollockJMDohertyTMSpecific immune-based diagnosis of tuberculosisLancet200035692351099110411009160
PubMed Web of Science ®Google Scholar
PapayPEserAWinklerSPredictors of indeterminate IFN-gamma release assay in screening for latent TB in inflammatory bowel diseasesEur J Clin Invest201141101071107621413978
PubMed Web of Science ®Google Scholar
HelwigUMullerMHedderichJSchreiberSCorticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patientsJ Crohns Colitis20126441942422398067
PubMed Web of Science ®Google Scholar
BélardESembSRuhwaldMPrednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infectionInflamm Bowel Dis201117112340234921319275
PubMed Web of Science ®Google Scholar
KayJUpchurchKSACR/EULAR 2010 rheumatoid arthritis classification criteriaRheumatology (Oxford)2012;51Suppl 6vi5vi923221588
PubMed Web of Science ®Google Scholar
FerraraGLosiMMeacciMRoutine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infectionAm J Respir Crit Care Med2005172563163515961696
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date